STOCK TITAN

[Form 4] Kewaunee Scientific Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Kewaunee Scientific (NASDAQ: KEQU) filed a Form 4 disclosing that Vice President-Information Technology Mandar Ranade was granted 4,392 restricted stock units (RSUs) on 25 June 2025.

The award converts to an equal number of common shares at a $0 exercise price. 50 % of the RSUs are service-based, vesting in three equal annual installments beginning 30 June 2026, while the remaining 50 % are performance-based and vest only if three-year performance goals are achieved. Following the grant, the reporting person beneficially owns 4,392 derivative securities. No shares were sold or otherwise disposed of.

Kewaunee Scientific (NASDAQ: KEQU) ha presentato un modulo Form 4 comunicando che il Vicepresidente dell'Information Technology, Mandar Ranade, ha ricevuto 4.392 unità azionarie vincolate (RSU) il 25 giugno 2025.

Il premio si trasforma in un numero equivalente di azioni ordinarie con un prezzo di esercizio di $0. Il 50% delle RSU è basato sul servizio, con maturazione in tre rate annuali uguali a partire dal 30 giugno 2026, mentre il restante 50% è basato sulle performance e matura solo se vengono raggiunti gli obiettivi di performance triennali. Dopo la concessione, la persona segnalante detiene beneficiariamente 4.392 titoli derivati. Non sono state vendute o cedute azioni.

Kewaunee Scientific (NASDAQ: KEQU) presentó un Formulario 4 revelando que el Vicepresidente de Tecnología de la Información, Mandar Ranade, recibió 4,392 unidades restringidas de acciones (RSU) el 25 de junio de 2025.

El premio se convierte en un número igual de acciones comunes con un precio de ejercicio de $0. El 50% de las RSU está basado en el servicio, con adjudicación en tres cuotas anuales iguales a partir del 30 de junio de 2026, mientras que el otro 50% está basado en el desempeño y solo se adjudica si se alcanzan los objetivos de desempeño a tres años. Tras la concesión, la persona informante posee beneficiosamente 4,392 valores derivados. No se vendieron ni dispusieron acciones de otro modo.

Kewaunee Scientific (NASDAQ: KEQU)는 부사장-정보기술 Mandar Ranade가 2025년 6월 25일에 4,392개의 제한 주식 단위(RSU)를 부여받았음을 공개하는 Form 4를 제출했습니다.

이 수상은 행사가격 $0로 동일한 수의 보통주로 전환됩니다. RSU의 50%는 서비스 기반으로, 2026년 6월 30일부터 시작하여 3년에 걸쳐 세 번에 나누어 취득되며, 나머지 50%는 성과 기반으로 3년 성과 목표 달성 시에만 취득됩니다. 부여 후 보고자는 4,392개의 파생 증권을 실질적으로 소유하고 있습니다. 주식은 매도되거나 기타 방법으로 처분되지 않았습니다.

Kewaunee Scientific (NASDAQ: KEQU) a déposé un formulaire 4 révélant que le vice-président des technologies de l'information, Mandar Ranade, s'est vu attribuer 4 392 unités d'actions restreintes (RSU) le 25 juin 2025.

Cette attribution se convertit en un nombre égal d'actions ordinaires à un prix d'exercice de 0 $. 50 % des RSU sont basées sur le service, acquises en trois versements annuels égaux à partir du 30 juin 2026, tandis que les 50 % restants sont basés sur la performance et ne sont acquis que si les objectifs de performance sur trois ans sont atteints. Après l'attribution, la personne déclarant détient effectivement 4 392 titres dérivés. Aucune action n'a été vendue ou autrement cédée.

Kewaunee Scientific (NASDAQ: KEQU) reichte ein Formular 4 ein, in dem offengelegt wurde, dass der Vice President Information Technology Mandar Ranade am 25. Juni 2025 4.392 Restricted Stock Units (RSUs) erhalten hat.

Die Zuteilung wandelt sich in eine gleiche Anzahl von Stammaktien zu einem Ausübungspreis von 0 $ um. 50 % der RSUs basieren auf Dienstzeit und werden in drei gleichen jährlichen Raten ab dem 30. Juni 2026 fällig, während die übrigen 50 % leistungsbasiert sind und nur dann fällig werden, wenn die dreijährigen Leistungsziele erreicht werden. Nach der Zuteilung besitzt die meldende Person wirtschaftlich 4.392 derivative Wertpapiere. Es wurden keine Aktien verkauft oder anderweitig veräußert.

Positive
  • None.
Negative
  • None.

Kewaunee Scientific (NASDAQ: KEQU) ha presentato un modulo Form 4 comunicando che il Vicepresidente dell'Information Technology, Mandar Ranade, ha ricevuto 4.392 unità azionarie vincolate (RSU) il 25 giugno 2025.

Il premio si trasforma in un numero equivalente di azioni ordinarie con un prezzo di esercizio di $0. Il 50% delle RSU è basato sul servizio, con maturazione in tre rate annuali uguali a partire dal 30 giugno 2026, mentre il restante 50% è basato sulle performance e matura solo se vengono raggiunti gli obiettivi di performance triennali. Dopo la concessione, la persona segnalante detiene beneficiariamente 4.392 titoli derivati. Non sono state vendute o cedute azioni.

Kewaunee Scientific (NASDAQ: KEQU) presentó un Formulario 4 revelando que el Vicepresidente de Tecnología de la Información, Mandar Ranade, recibió 4,392 unidades restringidas de acciones (RSU) el 25 de junio de 2025.

El premio se convierte en un número igual de acciones comunes con un precio de ejercicio de $0. El 50% de las RSU está basado en el servicio, con adjudicación en tres cuotas anuales iguales a partir del 30 de junio de 2026, mientras que el otro 50% está basado en el desempeño y solo se adjudica si se alcanzan los objetivos de desempeño a tres años. Tras la concesión, la persona informante posee beneficiosamente 4,392 valores derivados. No se vendieron ni dispusieron acciones de otro modo.

Kewaunee Scientific (NASDAQ: KEQU)는 부사장-정보기술 Mandar Ranade가 2025년 6월 25일에 4,392개의 제한 주식 단위(RSU)를 부여받았음을 공개하는 Form 4를 제출했습니다.

이 수상은 행사가격 $0로 동일한 수의 보통주로 전환됩니다. RSU의 50%는 서비스 기반으로, 2026년 6월 30일부터 시작하여 3년에 걸쳐 세 번에 나누어 취득되며, 나머지 50%는 성과 기반으로 3년 성과 목표 달성 시에만 취득됩니다. 부여 후 보고자는 4,392개의 파생 증권을 실질적으로 소유하고 있습니다. 주식은 매도되거나 기타 방법으로 처분되지 않았습니다.

Kewaunee Scientific (NASDAQ: KEQU) a déposé un formulaire 4 révélant que le vice-président des technologies de l'information, Mandar Ranade, s'est vu attribuer 4 392 unités d'actions restreintes (RSU) le 25 juin 2025.

Cette attribution se convertit en un nombre égal d'actions ordinaires à un prix d'exercice de 0 $. 50 % des RSU sont basées sur le service, acquises en trois versements annuels égaux à partir du 30 juin 2026, tandis que les 50 % restants sont basés sur la performance et ne sont acquis que si les objectifs de performance sur trois ans sont atteints. Après l'attribution, la personne déclarant détient effectivement 4 392 titres dérivés. Aucune action n'a été vendue ou autrement cédée.

Kewaunee Scientific (NASDAQ: KEQU) reichte ein Formular 4 ein, in dem offengelegt wurde, dass der Vice President Information Technology Mandar Ranade am 25. Juni 2025 4.392 Restricted Stock Units (RSUs) erhalten hat.

Die Zuteilung wandelt sich in eine gleiche Anzahl von Stammaktien zu einem Ausübungspreis von 0 $ um. 50 % der RSUs basieren auf Dienstzeit und werden in drei gleichen jährlichen Raten ab dem 30. Juni 2026 fällig, während die übrigen 50 % leistungsbasiert sind und nur dann fällig werden, wenn die dreijährigen Leistungsziele erreicht werden. Nach der Zuteilung besitzt die meldende Person wirtschaftlich 4.392 derivative Wertpapiere. Es wurden keine Aktien verkauft oder anderweitig veräußert.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ranade Mandar

(Last) (First) (Middle)
2700 WEST FRONT STREET

(Street)
STATESVILLE NC 28677

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP-Information Technology
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units FY26 (1) 06/25/2025 A 4,392 (2) (2) Common Stock 4,392 $0 4,392 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
2. The award of restricted stock units shall vest as follows: (a) 50% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning June 30, 2026, subject to the reporting person's continued employment with the Company; and (b) 50% of the number of restricted stock units subject to the award consist of performance-based restricted stock units that will vest only if performance goals are achieved over a three-year period. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the three-year performance period.
Remarks:
/s/ Donald T. Gardner III, Attorney-in-fact 06/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity award did KEQU disclose for its VP-IT on 25 June 2025?

KEQU granted 4,392 restricted stock units to Vice President-Information Technology Mandar Ranade, as reported in the Form 4.

How will the 4,392 RSUs granted to KEQU's VP-IT vest?

50 % vest in three equal annual installments starting 30 June 2026; the other 50 % vest only if three-year performance goals are met.

Did the Form 4 report any share sales by KEQU's insider?

No. The filing shows only an acquisition of RSUs; there were no dispositions of KEQU common stock.

How many derivative securities does the insider hold after the reported transaction?

After the grant, Mandar Ranade beneficially owns 4,392 RSUs relating to KEQU common shares.
Kewaunee Scienti

NASDAQ:KEQU

KEQU Rankings

KEQU Latest News

KEQU Latest SEC Filings

KEQU Stock Data

105.36M
2.13M
24.44%
44.44%
1.62%
Furnishings, Fixtures & Appliances
Laboratory Apparatus & Furniture
Link
United States
STATESVILLE